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Pregnancy-specific stress predicts birth outcomes.We hypothesized that there is amaternal stress-GR interaction that can influence
fetal birth weight. This study examined the relationship between mothers’ stress and attitude towards their pregnancies, placental
glucocorticoid receptors (GRs) and growth arrest-specific transcript 5 (GAS5) expression, and the status of GR polymorphism, with
their infants’ birth weights. GAS5 and GR𝛼were the predominant transcripts in both term and preterm placentas, with GAS5 being
primarily localized in the syncytiotrophoblasts. In an attempt to mimic moderate and high stress environment in vitro, BeWo and
JEG-3 cytotrophoblast cell lines were treated with 10 nM–1000 nM cortisol. Only expression of GAS5 was significantly upregulated
by cortisol in all treatments comparedwith basal levels, but none of theGRs changed expression significantly. In an attempt to assess
a stress versus gene interaction, we studied four GR polymorphisms. In the homozygous group for Tth111I polymorphism, mothers
with negative attitudes towards the pregnancy gave birth to infants with significantly lower birth weights compared to women with
positive/neutral attitudes. None of the GR splice variants were associated with maternal stress. However, placental GAS5 levels
were inversely correlated with maternal stress. This study points towards a potential gene-environment interaction that could be of
predictive value for fetal weight.
1. Introduction
Pregnancy is associated with major physiological and future
psychosocial changes and adaptation to these changes is
crucial for normal fetal development and for healthy infant-
mother relationships.Maternal pregnancy-specific stressmay
be a more powerful contributor to birth outcomes than
general stress [1]. Biologically, the stress hormone cortisol acts
by activating glucocorticoid receptors (GRs). To date, four
splice variants of the GR gene have been reported, formed
by alternative splicing, termed GR𝛼, GR𝛽, GR𝛾, and GR-P
[2]. Numerous studies have also reported the expression of
different GR splice variants in different cell and tissue types
[3–6]. Growth arrest-specific transcript 5 (GAS5) encodes
a single strand noncoding RNA (ncRNA) and, as its name
suggests, can accumulate in growth-arrested cells [7]. In a
recent study by Kino and colleagues it was demonstrated
that GAS5 ncRNA may be a repressor for the GR by acting
as a decoy “glucocorticoid response element (GRE),” thus,
competingwithDNAGREs for binding to theGR.As a result,
GRs cannot bind to their DNA GRE and subsequently their
function is compromised [8].
Changes in the epigenetic regulation of the fetal GR pro-
moter have been associated with exposure to prenatal
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maternal stress [9] reflecting a possible effect of maternal
stress on the expression and function of the GR in the
fetus. A GR BclI polymorphism has been associated with
increased glucocorticoid sensitivity and was overrepresented
in pregnant women with pathological, fetomaternal immune
adaptation. Indeed, a number of polymorphisms have been
described in the gene coding for the GR although it is
still unclear whether the variability in the glucocorticoid
responses observed is due to the polymorphisms or to
other factors [10]. This sensitivity could be one mechanism
linking maternal stress to fetal development. Only few of
these polymorphisms are functionally relevant and these
are the Tth111I, the ER22/23EK, the N363S, the—already
mentioned—BclI, and the GR-9𝛽. Studies have shown that
at least three polymorphisms are associated with altered
glucocorticoid sensitivity and also with changes in body
composition and metabolic parameters [10, 11], which could
affect fetal development as well.
This study examined the relationship between mothers’
stress levels and attitude towards their pregnancies, placental
GR and GAS5 expression, and the status of GR polymor-
phism,with their infants’ birthweights.We also examined the
maternal attitude versus gene interaction in relation to fetal
birth weight. Moreover, we tested the effect of cortisol on GR
splicing and GAS5 expression of BeWo and JEG-3 placental
cells, in an attempt to resemble a low, moderate, and high
stress milieu in vitro.
2. Methodology
2.1. Subjects. The study population consisted of pregnant
women attending the Department of Obstetrics and Gynae-
cology, University Hospital, University of Crete. The par-
ticipants were in the third trimester of their pregnancy.
All participants gave informed consent to participate in the
study and ethical approval was granted by the local ethics
committee of the hospital. Questionnaires regarding mater-
nal stress/maternal attitudes as well as anthropometric data
were collected as previously described [12, 13]. Briefly, mater-
nal stress/maternal attitudes towards their pregnancy were
assessed in the 3rd trimester, using a questionnaire approach.
A research nurse or a gynecologist conducted a face-to-
face interview with each woman lasting approximately 20–
30 minutes. Maternal attitudes were related to self-reported
stress status ranging from low and medium (low stress
response) to high and very high (high stress response). The
exact cause of maternal stress was not identified. Maternal
attitudes were divided into two groups: negative attitudes
(48%) and positive (35.7%)/neutral attitudes (16.3%). Imme-
diately after delivery the weight of the newbornwas recorded.
2.2. Placental Tissue. Placental tissues were obtained from
women delivering at term (>37 weeks of gestation) and
preterm (<37 weeks of gestation) (total 𝑛 = 23). Of the 13
term placentas 12 were in labor (mode of delivery: 10 cae-
sarean sections [CS], 2 vaginal deliveries) and 1 nonlabor/CS
tissue. None of the term or preterm women were adminis-
tered any antidepressants or synthetic glucocorticoids during
pregnancy. Of the 10 term placentas 4 were nonlabor and all
CS, and 6 were from laboring tissues (mode of delivery: 3
CS, 3 vaginal deliveries). The average age was 29.6 ± 4 years,
the mean pregnancy days were 240 ± 42, and mean fetal
weight was 2805 ± 95 gr. After delivery, thematernal and fetal
surfaces of the placenta were dissected, and fetal membranes
were peeled away from the placenta. Placental samples were
washed in PBS and immediately stored in RNAlater (Applied
Biosystems, UK) at−80∘C. Ethical approval was granted from
the local ethics authority.
2.3. Cell Culture. BeWo and JEG-3 cell lines were main-
tained at standard culture conditions of 5% CO
2
in air at
37∘C. BeWo cells were cultured in Ham F12 (Sigma-Aldrich,
UK) containing 10% heat-inactivated fetal bovine serum
(FBS) and 0.5% penicillin streptomycin, whereas JEG-3 cells
were maintained in MEME (Sigma-Aldrich, UK) containing
10% heat-inactivated FBS and 0.5% penicillin streptomycin,
0.5% L-glutamine, 0.5% sodium pyruvate, and 0.5% MEM
nonessential amino acids. Prior to cortisol treatment, both
cell lines were maintained for 3 hours in phenol red-free
media containing charcoal stripped FBS.
2.4. RNA Isolation, cDNA Synthesis, and PCR. Total ribonu-
cleic acid was isolated using an RNA extraction kit (Sigma-
Aldrich, UK), according to manufacturer’s instructions. RNA
concentration was determined by spectrophotometric analy-
sis (NanoDrop; Thermo Scientific, UK) and agarose gel elec-
trophoresis. RNA (200 ng from placental tissue and 500 ng
from cell lysates) was reverse-transcribed into cDNA using
5 IU/𝜇L RNase H reverse transcriptase (Invitrogen, Paisley,
UK).
2.5. Quantitative RT-PCR. Relative expression of the genes of
interest was assessed by quantitative PCR (Q-PCR) on anABI
Prism 7900HT Sequence detection system (Applied Biosys-
tems) using SYBR Green-PCR reaction mixture (Sigma-
Aldrich, UK) and specific primers (Table 1) as previously
described [14]. For the quantitative PCR, the following equa-
tions were used: ΔCt = Ct
(gene of interest) − Ct(house keeping gene),
ΔΔCt = ΔCt
(sample) − ΔCt(calibrator), and Relative Quantity
(RQ) = 2−ΔΔCt as previously described [12].
2.6. Immunofluorescent Analysis. Following a series of depar-
affinisation and dehydration, placental tissue sections were
incubated with 10% bovine serum albumin (BSA) for 1 hr.
This was followed by incubation for 1 hr with antibodies
against GR𝛼 at a 1 : 200 dilution in 1% BSA/PBS. Cells were
then washed with PBS prior to an incubation with a TRITC-
conjugated secondary antibody (Santa Cruz Biotechnology,
USA) for 1 hr. Slides were washed with PBS and mounted
in Vectashield Mounting Medium (Vector Labs) containing
the dye 4,6-diamido-2-phenylindole (DAPI) to counterstain
nuclei. Images were captured using a Plan Apo Neofluor
63X NA 1.25 oil objective (Zeiss) on a Zeiss Axiovert 200M
microscope and viewed using the AxioVision software.
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2.7. Western Immunoblotting. Proteins from placental lysates
and BeWo cells treated with 10–1000 nM cortisol were sepa-
rated on an SDS-12% polyacrylamide gel and transferred to
a nitrocellulose membrane. The membrane was blocked in
TBS containing 5%driedmilk powder (w/v) and 0.1%Tween-
20, overnight at 4∘C. After three washes with TBS-0.1%
Tween-20, the nitrocellulosemembraneswere incubatedwith
primary antibodies against GR𝛼/𝛽 (Abcam, ab3580, UK) and
GAPDH (Sigma-Aldrich, UK). The primary antisera were
used at a 1 : 1000 dilution for GR𝛼/𝛽 and 1 : 2000 for GAPDH,
overnight at 4∘C. The membranes were washed thoroughly
for 30min with TBS-0.1% Tween, before incubation with the
secondary HRP-conjugated immunoglobulin (1 : 2000) for
1 hr at room temperature and further washing for 30minwith
TBS-0.1% Tween-20. The immunoreactive bands were ana-
lyzed using Image J 1.34s image-analysis software (National
Institute of Health, USA).
2.8. RNA Fluorescent In Situ Hybridization (FISH). The slides
of the paraffin embedded placental tissue sampleswere placed
in a coplin jar and deparaffinised for 30minutes at 37∘C using
Histo-Clear (Fisher Scientific, UK). Thereafter, the tissue
sections were rehydrated by placing the slides in ethanol
solution of different concentrations (100%, 90%, 80%, 70%,
50%, and 30%) for 3 minutes. A brief wash in 1x PBS solution
was performed after this. Pepsin (0.01% in 0.01M HCl) was
used to treat the tissue for 5 minutes at 37∘C, and a brief rinse
inDEPC treatedH
2
O followed.Then, the tissue samples were
dehydrated by placing them in ethanol solutions (70%, 90%,
and 100%) for 5 minutes. A specific Alexa 488-conjugated
GAS5 hybridization probe (GTGCTATCCAGAGCCACA-
CTGCATCTGCACCCAGCACCATACCTCACAG) was
utilised as previously described [8] and followed by an
overnight incubation at 37∘C in a humidified chamber. After
this incubation, three 10-minute washes were followed in
2xSSC at 37∘C. The slides were then briefly rinsed in DEPC
treated H
2
O and mounted in Vectashield Mounting Medium
containing DAPI prior to examining the emitted fluorescent
signal under a Zeiss Axiovert 200Mmicroscope viewed using
the AxioVision software.
2.9. GR Polymorphisms. For the BclI, N363S, Tth111I, and
ER22/23EKGRpolymorphismsDNAwas extracted using the
Phusion Blood Direct PCR Kit (New England Biolabs, UK),
according to the manufacturer’s instructions. For the BclI,
the following primers were used: 5󸀠-AAGCTTAACAAT-
GGCCAT-3󸀠 and 5󸀠-TGCTGCCTTATTTGTAAATTCGT-
3󸀠. The PCR conditions used were 40 cycles of 98∘C for 5 sec,
annealing at 50∘C for 5 sec, and elongation at 72∘C for 15 sec.
To confirm the presence of the BclI polymorphism, 17 𝜇L of
the PCR product was digested with 2𝜇L of 10x Restriction
Endonuclease Buffer and 15U of the restriction enzyme BclI
(New England Biolabs, UK) for 1.5 hr at 50∘C. The resulting
digested fragments were separated on a 2% agarose gel to
determine the genotypes. For the N363S polymorphism, spe-
cific PCR primers were used: 5󸀠-AGTACCTCTGGAGGACA
G AT-3󸀠 and 5󸀠-GTCCATTCTTAAGAAACAGG-3󸀠 under
the same PCR conditions. The restriction enzyme Tsp509I
(10U) was used to digest the PCR products at 65∘C for
4 hours. For the ER22/EK23 polymorphism, we have used
the following primers: 5󸀠-GATTCGGAGTTAACTAAAAG-
3󸀠 and 5󸀠-CTACCCTTTACTGGACCCTA-3󸀠, followed by
restriction digest using MnI I (New England Biolabs, UK)
at 37∘C for 4 hours. Finally, the Tth111I polymorphism
was assessed using the PCR primers: 5󸀠-GGCCACAAC-
AATAACCCAGT-3󸀠 and 5󸀠-CCTATGACACGTATTTTG-
TGAAAGT-3󸀠. The restriction endonuclease Tth111I (New
England Biolabs, UK) was used to digest the PCR products
at 65∘C for 4 hours.
2.10. Statistical Analysis. Q-PCR data are reported as the
mean ± SEM. Statistical analysis was performed by Student’s
t-test and by ANOVA. 𝑃 < 0.05 was regarded as statistically
significant. We also tested the relationships between con-
tinuous predictors (women’s age, stress) and infant weight,
using Pearson correlations and partial correlations (when
adjusting for age and BMI) and using t-tests for dichotomous
predictors (e.g., planned pregnancy) and ANOVA for testing
the relationship between attitude type and infant birthweight,
while controlling statistically for relevant confounders such
as mothers’ age, BMI, pregnancy planning, and pregnancy
nutritional habits.
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3. Results
3.1. Expression of Placental GAS5 and GRs. Quantitative
RT-PCR revealed that GAS5 and all GRs were expressed
in human placentas (𝑛 = 23); 13 were preterm labor
(<37 gestational weeks) and 10 were term (>37 gestational
weeks) labor, with GAS5 and GR𝛼 being the predominant
transcripts. In term labor, GR𝛼’s ΔCt was 0.244 compared
with 0.006 for GR𝛽, 0.006 for GR𝛾, 0.023 for GR-P, and
0.26 for GAS5. At preterm, the values were 0.278, 0.004,
0.003, 0.006, and 0.180 for GR𝛼, GR𝛽, GR𝛾, GR-P, and GAS5,
respectively (see Figure 1(a)). It is evident that the major
transcripts in the human placenta are GR𝛼 and GAS5. When
relative mRNA abundance was calculated, an approximate 4-
fold change in the GR𝛼/GR-P in the preterm labor group was
noted compared with the term group. In addition, a twofold
increase in theGR𝛼/GAS5 ratio was also noted in the preterm
group compared to the term group (see Table 2).
In term placentas, there was a significant correlation
between GR𝛽 and GR𝛾 (𝑟 = 0.580, 𝑃 = 0.038) and with GR-P
(𝑟 = 0.980, 𝑃 < 0.001). In the preterm group, the dynamics
of GR splicing were altered, since GR𝛼 correlated with GR-P
(𝑟 = 0.710, 𝑃 = 0.021) and GR𝛽 correlated with GAS5 (𝑟 =
0.792, 𝑃 = 0.011). However, no significant correlation was
noted in the preterm group between fetal weight or maternal
stress and the relative expression of GRs and GAS5. In the
term group, the only significant correlation was between
GAS5 and maternal stress (𝑟 = −0.711, 𝑃 = 0.021).
Due to ethical restrictions, we were only able to assess
the expression of GR𝛼/𝛽 in 4 term and 3 preterm placentas.
Since GR is present as different isoforms,multiple bands were
observed and there was an expected interpatient variation in
the protein expression. Scanning densitometry of the bands
corresponding to GR𝛼/𝛽 normalized over GAPDH revealed
no apparent differences in the expression of these variants
between the term and the preterm groups (Figure 1(b)).
3.2. Cellular Distribution of GR𝛼 and GAS5 in Human Pla-
centas. Immunofluorescence analysis of the GR𝛼 protein
was performed in human placenta tissue sections. Strong
homogeneous staining mainly in the cytoplasm is detected
in the syncytiotrophoblast cells on the outermost layer of
the placental villi, with some scattered expression in cytotro-
phoblast cells (Figure 2(a)). UsingRNAFISH,GAS5 localized
primarily in syncytiotrophoblasts (Figure 2(c)). This is a first
time that GAS5 localization has been studied in human
placentas.
3.3. Effects of Cortisol on GRs and GAS5 In Vitro. BeWo
and JEG-3 cells were treated overnight with cortisol, to
mimicmoderate andhigh stress environments in vitro. Before
doing so, the expression of GAS5 and GRs was examined in
BeWo and JEG-3 cells without administering cortisol. GAS5
was significantly lower in expression in JEG-3 cells when
compared to BeWo under basal conditions (Figure 3(a)). For
the GRs, significantly higher expression levels were detected
only for GR𝛾 and GR-P in the JEG-3 cells compared to the
BeWo cells (Figure 3(b)).
Table 2: Relative mRNA abundance of GR𝛼 over GR𝛽, GR𝛾, GR-P,
and GAS5.






When BeWo and JEG-3 cells were treated with cortisol
10 nM, 100 nM, or 1000 nM, the expression of GAS5 was
significantly upregulated (all 𝑃 < 0.05) compared with
their corresponding basal levels (Figure 4(a)). The maximal
stimulation for GAS5 was at 10 nM of cortisol in JEG-3 cells
and at 1000 nM in BeWo. None of the cell lines exhibited
dose dependency. However, cortisol treatments did not exert
any significant changes in the gene expression of GR𝛼
(Figure 4(b)), GR𝛽 (Figure 4(c)), GR𝛾 (Figure 4(d)), and
GR-P in either of the cell lines (Figure 4(e)). In addition,
there were no apparent changes in protein expression of
GR𝛼/𝛽 in BeWo cells treated with 10–1000 nM of cortisol,
corroborating the qPCR studies (data not shown).
3.4. Maternal and Infant GR Polymorphisms, Maternal Atti-
tudes, and Fetal Birth Weight. Four GR polymorphisms were
investigated: BclI, N363S, Tth111I, and ER22/23EK (Table 3).
Since the maternal attitude towards the pregnancy was a
significant predictor of fetal birth weight, we reexamined
this association as a function of the GR genepolymorphisms,
resembling a gene-environment interaction and statistically
controlling for mothers’ age, BMI, pregnancy planning, and
pregnancy nutritional habits, to remove any potential sources
of statistical bias that could skew our data.
Statistical analysis of the maternalTht111I polymorphism
has shown an inverse correlation between negative maternal
attitude and infant birth weight (𝑟 = −0.41, 𝑃 = 0.030),
only in Tht111I CC polymorphism subgroup. In Tht111I CT,
no significant correlations were noted, controlling for age,
BMI, pregnancy planning, and consumption of fast food
during pregnancy. These data point towards an interaction
between stress and genetics, since only in the CC polymor-
phic GR group did negative maternal attitude predict fetal
weight reduction, but not in the CT group, independent
of confounders. Hence, the effects of maternal attitudes on
fetal weight depend on the mother’s polymorphism of GR
gene. None of the remaining GR polymorphism subgroups
demonstrated any differential correlations between maternal
attitudes and fetal weight (data not shown).
4. Discussion
The present study extends previous findings and provides
evidence for the first time how maternal stress and GR
polymorphisms can potentially affect fetal outcome together.
As reviewed previously, prenatal maternal stress has been
shown to have long-term effects on the psychological as
































Figure 1: (a) Expression of GR𝛼, GR𝛽, GR𝛾, GR-P, and GAS5 in term (blue; 𝑛 = 13) and preterm (red; 𝑛 = 10) placentas. (b) Protein





Figure 2: (a) Immunofluorescent analysis demonstrated expression of GR𝛼 primarily in the syncytiotrophoblastic layer of term placentas.
(b) Negative control, confirmed specificity of immunostaining. (c) RNA FISH confirmed expression of GAS5 in cytotrophoblasts cells (dotted
arrows) and syncytiotrophoblasts cells (white arrows).
well as behavioral development of the offspring [15, 16]. In
our cohort, women with negative attitudes exhibited higher
levels of stress during pregnancy compared to women with
neutral/positive attitudes and gave birth to infants with
lower birth weights than those with positive/neutral attitudes
towards their pregnancy (500 gr difference [13]).
In terms of the polymorphisms analyses, only the
maternal Tth111I polymorphism was suggestive of a gene-
environment interaction since, only in Tth111I (CC), nega-
tive versus positive/neutral maternal attitudes towards the
pregnancy predicted fetal weight reduction, but not in the
Tth111I (GC) group, independent of important confounders.
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Figure 3: (a) Expression of GAS5 in BeWo and JEG-3 cells; ∗𝑃 < 0.05. (b) Expression of GR𝛼, GR𝛽, GR𝛾, and GR-P in BeWo and JEG-3















































































































































Figure 4: Effects of cortisol on the expression of GAS5 (a), GR𝛼 (b), GR𝛽 (c), GR𝛾 (d), andGR-P (e) in JEG-3 (red) and BeWo (blue) placental
cell lines. NS: no supplement, ∗𝑃 < 0.05.
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Table 3: Distribution of GR polymorphisms.
Polymorphism Nucleotide change Genotype Distribution (%)
𝑛 = 81





N363S Asp → Lys wt 79 (97.5)
Hmz 2 (2.5)
𝑛 = 81





ER22/23EK Arg → Lys wt 78 (96.3)
Htz 3 (3.7)
These confounders included women’s age and BMI and were
not explained by gestational age. Additionally, multiple other
immune symptoms and demographic variables tested were
also not predictive of fetal weight. This is the first time that a
gene-environment interaction between a GR polymorphism
and maternal attitudes towards pregnancy was found, in
relation to fetal weight. To this date there has been some
contradicting evidence as to the role of these polymorphisms
in fetal outcomes [17–19].
The human placenta is exposed to increased levels of
cortisol as pregnancy progresses [20] and its effects are
mediated via binding and activating the GR. However, con-
troversy surrounds the exact mechanisms by which these
responses are regulated. GR alternative splicing might also
influence the subsequent activation of signalling pathways
by glucocorticoids [20]. In our study, we have shown that
all known transcripts of GR splice variants are expressed
in the human placenta with GR𝛼 being the predominant
transcript in all categories studied. These data corroborate a
previous preliminary study of placental GRs [20]. Moreover,
we demonstrate for the first time the expression of GAS5 in
human placentas. We decided to incorporate GAS5 in the
current study as it can act as a GR DNA binding decoy and
as a result compromise its activity [8]. Interestingly, GAS5
and GR𝛼 were the predominant transcripts in both term and
preterm placentas.
Here, we provide further information about the regula-
tion of this transcript by cortisol using two in vitromodels as
it is upregulated by cortisol in a dose-independent manner.
This finding provides further evidence of regulation of GAS5
by stress and corroborates initial in vivo data in mice [21].
In this study using C57BL/6 male mice, stress induced
GAS5 RNA levels in the hippocampus and this increase was
accompanied by a rise of corticosterone levels [22]. These in
vitro and in vivo observations together are highly suggestive
of a functional link between stress and this ncRNA.Moreover,
when we performed RNA FISH, the GAS5 transcript was
localized almost exclusively in the syncytiotrophoblast layer
of the human placenta and colocalizes GR𝛼. In view of
previous data in HeLa cells, where GAS5 translocates from
the cytoplasm into the nucleus with GR in response to
dexamethasone [8], this colocalization is highly suggestive of
a potential crosstalk at placental level between GAS5 and the
GR.
Preterm labor is associated with high mortality and
morbidity [22] and a recent study pointed towards an
association between maternal stress and complications of
pregnancy, especially preterm birth [23]. GR𝛽 differs from
GR𝛼 on the C-terminus of the receptor protein. There is
some controversy surrounding the exact function of GR𝛽,
but it appears to exert a dominant-negative effect on GR𝛼-
induced transcriptional activity [8]. Moreover, it fails to
bind glucocorticoids and activate subsequent transcriptional
events [24]. GR𝛾 is a ligand-dependent transcription factor
with reduced transactivating activity and its function is still
under investigation. In our clinical samples, GR𝛾 is present
at much lower levels than the GR𝛼 isoform in the placentas
studied. Similarly, little is known about the role of GR-P, a
truncated isoform that lacks a large part of the ligand-binding
domain, including the domains for silencing of GR in the
absence of hormone and transcriptional activation [24].
In our study, an approximate 4-fold change in the
GR𝛼/GR-P in preterm labor was detected. Johnson et al.
have shown that placental GR-P mRNA levels were reduced
significantly after spontaneous labor [20]. A twofold increase
in the GR𝛼/GAS5 ratio was also noted in the preterm group
compared with the term group of women. It is attractive
therefore to hypothesise that the change in the ratio of the
splicing isoforms alters the responsiveness of placental GRs to
cortisol and that thismay affect gestational age.Wewould like
to propose a potential model where, during preterm birth,
GR𝛼 is the predominant receptor since there is a decrease
in negative regulators such as GR𝛽, GR𝛾, and the “pseudo-
GRE” GAS5. These ratio changes will ultimately lead to an
augmented response towards glucocorticoids with potential
detrimental effects for the mother and the fetus. It is possible
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that this change of relative transcript abundance ratio might
be involved in the correlation between negative maternal
attitudes (hence highly stressed) and fetal birth weight.
In terms of the polymorphic study, our study provides
a novel insight into the involvement of GR polymorphisms
in pregnancy outcome. We have identified a specific group
of mothers (ThtIIII polymorphism, CC group) in whom
maternal attitudes predicted fetal weight. In a past study,
a similar gene-environment interaction was noted between
the ER22/23EK polymorphism and the effect of childhood
adversity on depression [17].
We acknowledge that measurement of GR polymor-
phisms posed certain limitations, for example, the use of cell
lines as in vitro experimentalmodels. Although both cell lines
(JEG-3 andBeWo) could represent a cytotrophoblasticmilieu
in vitro, they have differences in their fusogenic capacities.
In addition, microarray analyses demonstrated that many
transcripts were differentially expressed between JEG-3 and
BeWo cells [25]. It would be of interest to repeat these experi-
ments in primary cell lines of syncytialised trophoblasts.This
experiment would provide a better insight into the regulation
of GAS5 by cortisol. However and despite these limitations,
there is a wealth of literature using those two cell lines as
experimental models to study placental function. It would
also be of interest to expand these observations in human
myometrium that is a key organ responsible for quiescence
and contractility responses and also assess whether changes
in GR transcripts are due to labor or nonlabor. To test this,
we have performed qPCR for all GRs and GAS5 in the same
cohort of placentas divided this time to labor (𝑛 = 18) and
nonlabor (𝑛 = 5). There was no apparent change in the
expression of any of the genes in these two categories (data
not shown).Therefore, at placental level, the contractile status
does not really affect GR transcription.
We acknowledge that our sample included small numbers
in certain categories of polymorphic groups. Moreover, the
nature of maternal stress was not identified and further ana-
lytical approaches are needed to provide conclusive evidence
for a gene-environment interaction. Nevertheless, the statis-
tically significant effect and the size of differences observed
between mothers with negative versus positive and neutral
attitudes in theTht111I CC polymorphism group suggest that
this effect may be robust. Second, the distribution of BclI
polymorphism seen in this sample may be unique, since
there are important geographical/ethnic differences in the
prevalence of these polymorphisms. It should be emphasized
that, in the present study, we included a fairly homogeneous
cohort of Mediterranean patients from Crete. Despite these
limitations, this is the first study to demonstrate a gene-
maternal environment synergism in relation to infant birth
weight, using a very brief assessment of maternal attitudes to
pregnancy. Should these data be replicated in a much wider
cohort, given the simplicity in assessing such attitudes and
the feasibility to identify the homozygous group of women
early on in pregnancy, these findings may have significant
implications for public health and prevention. For example,
based on the polymorphic profile and our brief assessment
of mothers’ attitude towards the pregnancy, we could screen
noninvasively and identify mothers during pregnancy that
may benefit from stress-management strategies, and this
could possibly dramatically improve health outcomes for the
mother as well as the fetus.
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